MUMBAI, India, Sept. 5 -- Intellectual Property India has published a patent application (202441010845 A) filed by Satyarx Pharma Innovations Pvt. Ltd., Hyderabad, Telangana, on Feb. 16, 2024, for 'novel heteroaryl compounds as usp1 inhibitors.'
Inventor(s) include Sathyanarayana Murthy Chavali.
The application for the patent was published on Sept. 5, under issue no. 36/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to novel heteroaryl compounds of formula (I) as USP1 inhibitors, or it's pharmaceutically acceptable salts, solvates, polymorphs, tautomers, atropisomers, optical and geometric isomers, isotopes, prodrugs or deuterated compounds including their isotopes, combinations and use thereof."
Disclaimer: Curated by HT Syndication.
